Europe Medical Affairs Outsourcing Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

The Europe medical affairs outsourcing market size was valued at USD 217.1 million in 2019 and expanding at a CAGR of 9.5% over forecast period 2020 to 2027.

The market growth can be attributed to the increase in the number of clinical trials and orphan therapies as well as a rise in the prevalence of rare diseases in Europe.

In addition, pharmaceutical and medical devices companies are outsourcing these services to Contract Research Organizations (CROs) to limit the liability exposure by working with a well-trained outsource company, lower operational costs, reduce regulatory compliance risk, and minimize process delays. Medical affairs service providers have grown significantly in the region owing to rising R&D expenditure and increasing focus of pharmaceutical companies on containing cost.

Biopharmaceutical companies are now ready to outsource their medical affairs activities to achieve better quality and cost. This trend is expected to continue in the future due to the increase in capabilities of CROs to manage each medical affairs function, which would reduce the need for additional efforts of biopharmaceutical companies. Collaborations of pharmaceutical, biopharmaceutical, and medical device companies with CROs are also expected to have a positive impact on the market.

The medical affairs department separates commercial and R&D functions to reduce commercial influence on R&D due to increased scrutiny of the promotion of a therapeutic product by regulatory agencies. It acts as a liaison between the two functions, facilitating the transition of drugs from R&D to commercial. Such stringent regulations are expected to drive the outsourcing of medical affairs activities to more efficient third-parties.

Market Study

• The medical writing & publishing segment accounted for the largest revenue share of more than 32.1% in 2019. Medical Science Liaisons (MSLs) are expected to be the fastest-growing segment over the forecast period.
• The pharmaceutical industry segment accounted for the largest revenue share of more than 51% in 2019. The segment is projected to retain its dominant position throughout the forecast years owing to surge in patent expiration.
• Germany market accounted for the largest revenue with 53% share in 2019 and is expected to continue its dominance over the forecast period.

Some prominent players in the market include:

• Syneos Health Inc.

• Ashfield Healthcare Communications

• ZEINCRO Group

• Wuxi Clinical Development, Inc.

• SGS SA

• ICON plc

• IQVIA Holdings Inc.

• The Medical Affairs Company (TMAC)

• Indegene

• PPD Inc.

Market Segmentation

Services Outlook

• • Medical Writing & Publishing

  • Medical Monitoring

  • Medical Science Liaisons (MSLs)

  • Medical Information

  • Others

Industry Outlook

• • Pharmaceutical

  • Biopharmaceutical

  • Medical Devices

    • Therapeutic Medical Devices

    • Diagnostic Medical Devices

Country Outlook

• • Europe

    • The U.K.

    • Germany

    • France

    • Italy

    • Spain